Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the Litx™ system is safe and effective in
combination with chemotherapy in the treatment of liver metastasis arising from colorectal
cancer. Litx™ is a next-generation photodynamic therapy platform in which the drug,
talaporfin sodium (LS11), is activated by light from the light-emitting diode (LED)-based
light infusion device, inserted directly into the tumor through the skin prior to treatment.